Beckmann H, Ludolph E
Arzneimittelforschung. 1978;28(8):1283-4.
In an open study dl-phenylalanine in doses from 75--200 mg/day was administered to 20 depressed patients for 20 days. At the end of the trial 12 patients (8 with complete, 4 with good response) could be discharged without any further treatment. 4 patients with partially untypical depressions experienced mild to moderate responses, whereas 4 patients did not respond at all to the phenylalanine administration. Depressive "core symptoms" as depressed mood, retardation and/or agitation were preferentially, anxiety and sleep disturbances moderately and hypochondriasis and compulsiveness were not influenced. It is concluded that dl-phenylalanine might have substantial antidepressant properties and that further controlled investigations are justified.
在一项开放性研究中,对20名抑郁症患者给予剂量为75 - 200毫克/天的消旋苯丙氨酸,持续20天。试验结束时,12名患者(8名完全缓解,4名有良好反应)无需进一步治疗即可出院。4名患有部分非典型抑郁症的患者有轻度至中度反应,而4名患者对苯丙氨酸给药完全没有反应。抑郁“核心症状”如情绪低落、迟缓及/或激越优先得到改善,焦虑和睡眠障碍得到中度改善,而疑病症和强迫行为未受影响。得出的结论是,消旋苯丙氨酸可能具有显著的抗抑郁特性,进一步的对照研究是合理的。